About TScan Therapeutics, Inc. 
TScan Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 24 Schemes (15.05%)
Foreign Institutions
Held by 44 Foreign Institutions (18.35%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Sep 2025)
Net Profit:
-36 Million
Pharmaceuticals & Biotechnology
USD 60 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.01
-98.26%
0.42






